Fresenius Kabi USA, LLC

Form 483

Grand Island, New York, United StatesFEI 3001833549Issued January 13, 2010

View FDA's Record for This Firm

Source: FDA record for this establishment. FDA publishes inspections or enforcement actions for this establishment, listed further down this page, but we have not matched this particular Form 483 to a document or an inspection date FDA has released. It stays out of the default view for that reason. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3001833549.

Observations6

Issue DateJanuary 13, 2010

StatusNo Warning Letter

Related Inspections10

Establishment Details

Firm: Fresenius Kabi USA, LLC
Location: Grand Island, New York, United States
FEI Number: 3001833549
Product Type: Drugs
Issue Date: January 13, 2010
Country: United States

Inspection History, 2011 to 2023

NAI1

VAI7

OAI2

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Fresenius Kabi USA, LLC FDA Form 483, Grand Island, New York, January 13, 2010